Alkem's Revolutionary therapy TERIPARATIDE-GEMFRAC for weak bones now more accessible to all Indians Deeksha Bhandari12 Jun 2025 11:33 AM ISTIn a bid to make osteoporosis treatment affordable to Indian masses, Alkem Laboratories has slashed the price of its Teriparatide brand, Gemfrac.Until...
Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in stage IV metastatic gallbladder cancer - Dr AVS Suresh Deeksha Bhandari9 Jun 2025 12:00 PM ISTChemotherapy-induced anemia (CIA) is a serious complication in cancer patients, impacting treatment continuity and quality of life. In this video,...
Micro Labs Launches Sitanorm-E, Sitagliptin-Empagliflozin FDC for Uncontrolled Type 2 Diabetes in India Deeksha Bhandari6 Jun 2025 12:11 PM ISTMicro Labs has announced the launch of Sitanorm-E, a fixed-dose combination (FDC) of Sitagliptin and Empagliflozin. The combination is formulated to...
Sun Pharma Sets Record with Over 1 Lakh Uric Acid Screenings in 3 Days Deeksha Bhandari30 May 2025 1:07 PM ISTSun Pharmaceuticals has achieved a significant milestone by setting a national record for screening the highest number of individuals for uric acid...
Revolutionizing Medical Education: How AI is Accelerating CBME Implementation in India Deeksha Bhandari27 May 2025 11:46 AM ISTIndia is at a pivotal juncture in reshaping its healthcare ecosystem, driven by a burgeoning population, technological advancements, and a renewed...
Micro Labs Launches Sitanorm E: Sitagliptin + Empagliflozin FDC for diabetes patients in India Deeksha Bhandari26 May 2025 11:40 AM ISTMicro Labs has announced the launch of Sitanorm-E, a fixed-dose combination (FDC) of Sitagliptin and Empagliflozin for the management of ...
Meril presents successful LANDMARK RCT one-year results at prestigious EuroPCR 2025 Deeksha Bhandari23 May 2025 4:58 PM ISTFirst-of-its-kind head-to-head TAVI trial reinforces the performance and safety of the Next Gen Myval THV series
Ajanta Pharma Launches Met-XL D to Improve Outcomes for Heart Failure and Post-Myocardial Infarction Patients Deeksha Bhandari22 May 2025 12:30 PM ISTAjanta Pharma, one of the leaders in the cardiology segment has launched the fixed dose combination of Metoprolol and Dapagliflozin under the brand...
First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan Deeksha Bhandari15 May 2025 12:42 PM ISTA recent expert group consensus has endorsed the use of vonoprazan for managing refractory gastroesophageal reflux disease (rGERD) in Indian...
Ajanta Pharma Sets Worldwide Record for CPR Pledges MDTV Bureau9 May 2025 5:22 PM ISTAjanta Pharma has achieved a significant milestone by entering the Worldwide Book of Records for organizing the maximum number of pledges to train and...
Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer - Dr Aditya Murali Deeksha Bhandari9 May 2025 12:00 PM ISTCancer and chemotherapy-induced anemia (CIA) is a common complication in patients undergoing active chemotherapy, with or without radiation therapy....
7- Point Discharge Protocol for AECOPD: Time to Inculcate in Practice Deeksha Bhandari3 May 2025 12:41 PM ISTA recent consensus & expert recommendations published in the Primary Care Respiratory Medicine journal has revealed insightful facts. ...
